Eligibility for Transcatheter Tricuspid Valve Interventions in Patients With Tricuspid Regurgitation
JACC: Cardiovascular Interventions · 2024-12 · 17 (23) · 2732-2744
DOI: 10.1016/j.jcin.2024.09.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2024-12. Verfasst von Tetsu Tanaka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, University Hospital Bonn, Bonn, Germany. Electronic address: ta.chi.tsu.tetsu@gmail.com. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Cardiac Catheterization, Tricuspid Valve, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: It remains unclear what proportion of patients with tricuspid regurgitation (TR) are suitable candidates for transcatheter tricuspid valve intervention (TTVI) in clinical practice. OBJECTIVES: The aim of this study was to ascertain the prevalence of eligibility for tricuspid transcatheter edge-to-edge repair (T-TEER) and transcatheter tricuspid valve replacement (TTVR) devices among patients with TR. METHODS: The tricuspid valve anatomy of all consecutive patients with TR who were considered for TTVI in local heart team conferences was retrospectively reviewed. According to current expert consensus, the anatomical feasibility for T-TEER was classified into 3 groups: favorable, feasible, and unfavorable anatomy. Clinical and anatomical eligibility for TTVR was evaluated in patients with cardiac computed tomographic (CCT) images. RESULTS: Among 491 patients, 99 (20.2%) and 235 (47.9%) were considered to have favorable and feasible anatomy for T-TEER, respectively. In contrast, 157 patients (32.0%) had unfavorable anatomy for T-TEER. The most common reason for unfavorable anatomy for T-TEER was large coaptation gap width (66.2%), followed by anteroposterior TR jet location (62.4%). Among 327 patients with CCT images, 205 (62.7%) were judged to be clinically or anatomically ineligible for TTVR, mainly because of tricuspid annuli larger than commercially available prosthesis sizes (65.4%). Combined echocardiographic and CCT assessment showed that 23.2% of the patients with TR were ineligible for both T-TEER and TTVR. CONCLUSIONS: Of 491 patients requiring TTVI, 32.0% had unfavorable anatomy for T-TEER, and 37.3% of patients with CCT images were eligible for TTVR. Despite the emergence of TTVR devices, 23.2% of patients with TR remained ineligible for both T-TEER and TTVR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine II, University Hospital Bonn, Bonn, Germany. Electronic address: ta.chi.tsu.tetsu@gmail.com.
- Department of Internal Medicine II, University Hospital Bonn, Bonn, Germany.
- Department of Cardiac Surgery, University Hospital Bonn, Bonn, Germany.
Zitieren
APA
Tanaka, T., Vogelhuber, J., Öztürk, C., Silaschi, M., Bakhtiary, F., Zimmer, S., Nickenig, G., Weber, M., & Sugiura, A. (2024). Eligibility for Transcatheter Tricuspid Valve Interventions in Patients With Tricuspid Regurgitation. JACC: Cardiovascular Interventions, 17(23), 2732-2744. https://doi.org/10.1016/j.jcin.2024.09.019
Vancouver
Tanaka T, Vogelhuber J, Öztürk C, Silaschi M, Bakhtiary F, Zimmer S, et al. Eligibility for Transcatheter Tricuspid Valve Interventions in Patients With Tricuspid Regurgitation. JACC: Cardiovascular Interventions. 2024;17(23):2732-2744. doi:10.1016/j.jcin.2024.09.019
BibTeX
@article{Tanaka2024,
author = {Tanaka, Tetsu and Vogelhuber, Johanna and Öztürk, Can and Silaschi, Miriam and Bakhtiary, Farhad and Zimmer, Sebastian and Nickenig, Georg and Weber, Marcel and Sugiura, Atsushi},
title = {Eligibility for Transcatheter Tricuspid Valve Interventions in Patients With Tricuspid Regurgitation},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
volume = {17},
number = {23},
pages = {2732--2744},
doi = {10.1016/j.jcin.2024.09.019}
}
EUVIMED